Latest Period
Q1 2026
Security Snapshot
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) Institutional Ownership
CUSIP: 04683R106
13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026
Institutions Reporting
127
Shares (Excl. Options)
60,096,375
Price
$5.38
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- AVIR on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 60,096,375
- Total 13F value
- $322,768,077
- Portfolio coverage rank
- 0%
- Share change
- +2,875,170
- Value change
- +$18,119,687
- Number of holders
- 127
- Shares outstanding
- 79,671,812
- SEC-reported price per share
- $5.61
- Insider filing price
- $5.61
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK is tracked under CUSIP 04683R106.
- 127 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 111 to 127 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $203,464,380 to $322,768,077.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 127 institutions filings for Q1 2026.
Security key
04683R106
Latest holder period
Q1 2026
13F holders
127
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
AVIR full holder history
Atea Pharmaceuticals, Inc. SEC filings
Atea Pharmaceuticals, Inc. company facts
Atea Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 04683R106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
AVIR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | +28% | $68,238,907 | +$16,302,575 | 11,950,772 | +31% | FMR LLC | 31 Mar 2026 |
| Sommadossi Jean-Pierre | 10% | $26,185,536 | 8,876,453 | Jean-Pierre Sommadossi | 31 Mar 2025 | |||
| BML Investment Partners, L.P. | 9.9% | +16% | $27,881,700 | +$2,119,466 | 7,810,000 | +8.2% | Leonard Braden Michael | 31 Dec 2025 |
| BlackRock, Inc. | 7.1% | $17,942,932 | 6,082,350 | BlackRock, Inc. | 31 Mar 2025 | |||
| Radoff Bradley Louis | 4% | +10% | $9,971,295 | +$811,250 | 3,380,100 | +8.9% | Radoff Bradley Louis | 16 Apr 2025 |
| EcoR1 Capital, LLC | 4% | $9,857,876 | 3,341,653 | EcoR1 Capital, LLC | 31 Dec 2024 |
As of 31 Mar 2026, 127 institutional investors reported holding 60,096,375 shares of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR). This represents 75% of the company’s total 79,671,812 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
69%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 11,950,772 | +23% | 0% | $64,295,153 |
| BlackRock, Inc. | 11% | 8,435,437 | -0.66% | 0% | $45,382,652 |
| BML Capital Management, LLC | 8.9% | 7,058,657 | -5.8% | 24% | $37,975,575 |
| TANG CAPITAL MANAGEMENT LLC | 6% | 4,814,700 | 0% | 1.3% | $25,903,086 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 3,246,124 | 0% | 0% | $17,464,147 |
| Bain Capital Life Sciences Investors, LLC | 3% | 2,360,638 | -5% | 1.1% | $12,700,232 |
| TWO SIGMA INVESTMENTS, LP | 2.3% | 1,864,164 | +150% | 0.01% | $10,029,202 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,747,706 | -5.1% | 0% | $9,405,012 |
| STATE STREET CORP | 2.1% | 1,694,635 | -5% | 0% | $9,117,136 |
| ACADIAN ASSET MANAGEMENT LLC | 2% | 1,582,817 | +21% | 0.01% | $8,508,000 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 1,255,484 | -8.6% | 0% | $6,752,650 |
| Rosalind Advisors, Inc. | 1.5% | 1,171,855 | 2.6% | $6,304,580 | |
| RENAISSANCE TECHNOLOGIES LLC | 1.5% | 1,166,400 | -1.9% | 0.01% | $6,275,232 |
| JPMORGAN CHASE & CO | 1.2% | 940,157 | -30% | 0% | $4,775,998 |
| MORGAN STANLEY | 0.92% | 731,019 | +11% | 0% | $3,932,882 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.75% | 596,709 | -1.8% | 0% | $3,210,294 |
| GOLDMAN SACHS GROUP INC | 0.74% | 588,463 | +25% | 0% | $3,165,931 |
| NORTHERN TRUST CORP | 0.73% | 585,025 | +4.4% | 0% | $3,147,435 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.7% | 557,579 | 0% | 0% | $2,999,775 |
| VANGUARD FIDUCIARY TRUST CO | 0.61% | 484,705 | 0% | 0% | $2,607,713 |
| JANE STREET GROUP, LLC | 0.53% | 418,296 | +67% | 0% | $2,250,432 |
| D. E. Shaw & Co., Inc. | 0.48% | 379,314 | -18% | 0% | $2,040,710 |
| CM Management, LLC | 0.45% | 355,000 | 0% | 1.6% | $1,909,900 |
| MILLENNIUM MANAGEMENT LLC | 0.44% | 349,932 | -50% | 0% | $1,882,634 |
| BANQUE PICTET & CIE SA | 0.43% | 345,077 | 0% | 0.02% | $1,856,514 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Latest
Q1 2026
Rows shown
1-22 of 22
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 60,096,375 | $322,768,077 | +$18,119,687 | $5.38 | 127 |
| 2025 Q4 | 57,001,968 | $203,464,380 | +$14,036,645 | $3.57 | 111 |
| 2025 Q3 | 53,140,830 | $154,099,223 | +$874,820 | $2.90 | 112 |
| 2025 Q2 | 52,688,325 | $189,687,193 | -$496,611 | $3.60 | 105 |
| 2025 Q1 | 52,943,893 | $158,295,789 | -$11,408,006 | $2.99 | 102 |
| 2024 Q4 | 56,328,149 | $188,651,399 | -$6,772,701 | $3.35 | 103 |
| 2024 Q3 | 57,907,511 | $193,998,567 | +$4,533,749 | $3.35 | 105 |
| 2024 Q2 | 56,687,549 | $187,637,646 | +$7,123,002 | $3.31 | 101 |
| 2024 Q1 | 54,332,807 | $219,504,800 | -$1,664,806 | $4.04 | 112 |
| 2023 Q4 | 55,088,379 | $168,248,591 | -$1,691,841 | $3.05 | 106 |
| 2023 Q3 | 56,849,245 | $170,555,234 | -$2,209,314 | $3.00 | 117 |
| 2023 Q2 | 57,041,241 | $213,289,848 | +$971,494 | $3.74 | 131 |
| 2023 Q1 | 56,778,720 | $190,176,002 | -$5,878,803 | $3.35 | 128 |
| 2022 Q4 | 57,878,556 | $278,395,526 | -$5,016,357 | $4.81 | 130 |
| 2022 Q3 | 57,466,718 | $326,999,436 | -$1,731,457 | $5.69 | 115 |
| 2022 Q2 | 57,566,762 | $408,727,109 | +$19,469,875 | $7.10 | 122 |
| 2022 Q1 | 54,946,542 | $396,539,427 | +$6,369,699 | $7.22 | 121 |
| 2021 Q4 | 53,581,427 | $478,985,081 | -$368,375,568 | $8.94 | 134 |
| 2021 Q3 | 56,840,788 | $1,992,582,650 | -$21,707,203 | $35.06 | 137 |
| 2021 Q2 | 58,896,806 | $1,265,508,812 | +$160,923,836 | $21.48 | 100 |
| 2021 Q1 | 47,389,412 | $2,914,493,173 | +$30,510,569 | $61.75 | 78 |
| 2020 Q4 | 49,910,976 | $2,070,766,859 | +$1,819,869,860 | $41.78 | 69 |